Skip to Main Content

Author Details

Stephanie Peeters
University of Liege, Centre Hospitalier Universitaire de Liege
2005
82
27
PMIDPaper TitleJournal TitlePublished Year
37729845Analysis of progesterone and estrone-sulfate in feces of American Bison using liquid chromatography coupled to mass spectrometry: Technical validation and correlation with blood levels.Domest Anim Endocrinol2024
37918791Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease.Kidney Int2024
38039597Development and validation of an LC-MS/MS method for the simultaneous quantitation of angiotensin (1-7), (1-8), (1-9) and (1-10) in human plasma.J Chromatogr B Analyt Technol Biomed Life Sci2024
36870610Radiotherapy for mediastinal lymphoma in breath hold using surface monitoring and nasal high flow oxygen: Clinical experiences and breath hold stability.Radiother Oncol2023
37634391Innovative workflow for the identification of cathepsin K cleavage sites in type I collagen.J Chromatogr B Analyt Technol Biomed Life Sci2023
37130062Development and Validation of an Ultrasensitive LC-MS/MS Method for the Quantification of Melatonin in Human Saliva.J Am Soc Mass Spectrom2023
37397874Clinical evaluation of synthetic computed tomography methods in adaptive proton therapy of lung cancer patients.Phys Imaging Radiat Oncol2023
37128992Concise review on the combined use of immunocapture, mass spectrometry and liquid chromatography for clinical applications.Clin Chem Lab Med2023
36995129Analytical performance specifications for the measurement uncertainty of 24,25-dihydroxyvitamin D examinations.Clin Chem Lab Med2023
36912296Assessment of the Androstenedione Assay on a Roche Analytical Platform and Comparison with Different Methods.Clin Lab2023
36326243Corrigendum to "Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects" [Clin. Mass Spectrom. 9 (2018) 7-17].J Mass Spectrom Adv Clin Lab2022
35738034Evolution of 17-β-estradiol, estrone and estrone-sulfate concentrations in late pregnancy of different breeds of mares using Liquid Chromatography and Mass Spectrometry.Theriogenology2022
35602549Real-world analysis of manual editing of deep learning contouring in the thorax region.Phys Imaging Radiat Oncol2022
3593123325-OH Vitamin D concentrations measured by LC-MS/MS are equivalent in serum and EDTA plasma.Steroids2022
33295823Visually guided inspiration breath-hold facilitated with nasal high flow therapy in locally advanced lung cancer.Acta Oncol2021
33770524Development and validation of a liquid chromatography coupled to mass spectrometer (LC-MS) method for the simultaneous quantification of estrone-3-sulfate, progesterone, estrone and estradiol in serum of mares and American bisons.Res Vet Sci2021
33506627The Authors reply: Comment on: "Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy" by Burtin et al.J Cachexia Sarcopenia Muscle2021
33925139Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?Cancers (Basel)2021
34673091Optimal delineation of the clinical target volume for thymomas in the post-resection setting: A multi-center study.Radiother Oncol2021
34727586Comparison of two LC-MS/MS methods for the quantification of 24,25-dihydroxyvitamin D3 in patients and external quality assurance samples.Clin Chem Lab Med2021
34461185The impact of organ-at-risk contour variations on automatically generated treatment plans for NSCLC.Radiother Oncol2021
34538585Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART.Clin Lung Cancer2021
34010687Vitamin D Standardization Program (VDSP) intralaboratory study for the assessment of 25-hydroxyvitamin D assay variability and bias.J Steroid Biochem Mol Biol2021
34312396Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.NPJ Breast Cancer2021
33245945Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology.Radiother Oncol2021
33186683Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine.Radiother Oncol2021
33181149Development and validation of a fast and reliable method for the quantification of glucagon by liquid chromatography and tandem mass spectrometry.Clin Chim Acta2021
32162779A Field Study Method as a Potential Higher Tier Option to Refine Herbicide Risk Assessment for Nontarget Terrestrial Plants.Integr Environ Assess Manag2020
31804956Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects.Clin Chem Lab Med2020
32045108Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy.J Cachexia Sarcopenia Muscle2020
32069223The pathway through LC-MS method development: in-house or ready-to-use kit-based methods?Clin Chem Lab Med2020
31887577The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts.Radiother Oncol2020
32673777ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer.Radiother Oncol2020
32447035Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise.Radiother Oncol2020
30625341Establishment of reference intervals for serum concentrations of androstanediol glucuronide by a newly developed LC-MS/MS method.Steroids2019
31810511Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77].Radiother Oncol2019
31015173Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.Radiother Oncol2019
30935574Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.Radiother Oncol2019
29605476ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer.Radiother Oncol2018
30016964RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue.Radiat Oncol2018
30229951Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test.Med Phys2018
28840754Standard of care in high-dose radiotherapy for localized non-small cell lung cancer.Acta Oncol2017
28197653Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.Strahlenther Onkol2017
28358665Is there a different dose-effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study.Acta Oncol2017
28842174A fast and simple method for simultaneous measurements of 25(OH)D, 24,25(OH)<sub>2</sub>D and the Vitamin D Metabolite Ratio (VMR) in serum samples by LC-MS/MS.Clin Chim Acta2017
26819286Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.Eur J Cardiothorac Surg2016
27732127Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.Acta Oncol2016
27788387Postoperative radiotherapy for lung cancer: Is it worth the controversy?Cancer Treat Rev2016
27756544A simple LC-MS method for the determination of iohexol and iothalamate in serum, using ioversol as an internal standard.Clin Chim Acta2016
27686592Boost delineation in breast radiation therapy: Isotropic versus anisotropic margin expansion.Pract Radiat Oncol2016
  • 1 - 50 of 82

Recommended Authors

Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 0
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 0
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 0
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 1
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 0
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 0
Ascension Providence Hospital
Career Start Year 2005
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 0
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 15
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 0
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 0
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 0
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 3
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 1
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 7
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 15
University of California los angeles
Career Start Year 1996
Number of shared co-authors 0
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 15
Belgium International Drug Development Institute
Career Start Year 1995
Number of shared co-authors 3
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
university of california los angeles Medical Center
Career Start Year 1993
Number of shared co-authors 1
Maastricht University
Career Start Year 1992
Number of shared co-authors 12
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 1
Sir Charles Gairdner Hospital
Career Start Year 1990
Number of shared co-authors 1
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 0
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 4
Universita Cattolica del Sacro Cuore
Career Start Year 1983
Number of shared co-authors 7
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
University of Newcastle
Career Start Year 1980
Number of shared co-authors 0

Collaborators

Maastro Clinic
Co-authored papers 29
German Cancer Research Center (DKFZ)
Co-authored papers 7
Maastricht University Medical Center+
Co-authored papers 7
Co-authored papers 5
Instituto de Salud Carlos III
Co-authored papers 4
Ospedale Circolo e Fondazione Macchi
Co-authored papers 4
Pomeranian Medical University
Co-authored papers 4
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 4
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
Co-authored papers 4
QIMR Berghofer Medical Research Institute
Co-authored papers 4
University of Toronto
Co-authored papers 4
University of Cambridge
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
The Usher Institute, The University of Edinburgh
Co-authored papers 4
University of California irvine
Co-authored papers 4
Otto-Friedrich-University Bamberg
Co-authored papers 4
German Cancer Research Center (DKFZ)
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 3
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 3
UCSF Helen Diller Family Comprehensive Cancer Center
Co-authored papers 3
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Co-authored papers 3
University of Southern California
Co-authored papers 3
Co-authored papers 3